CE Search Engine Logo

E2: Evidence and Expert Insights on Novel Treatment Approaches for B-Cell Malignancies

Access Activity

Overview / Abstract:

Target Audience
This activity is designed to meet the educational needs of hematologists, oncologists, oncology nurses, nurse practitioners, PAs, pharmacists, and other healthcare professionals (HCPs) involved in the management of patients with B-cell malignancies.

Program Overview
A 45-minute online, learner-directed program featuring faculty presenting evidence on novel targeted therapies for B-cell malignancies, as well as expert insights into clinical considerations in the use of these agents.

Learning Objectives
Upon completion of this activity, participants should be better able to:

Review clinical data on the use of targeted therapies for B-cell malignancies
Utilize molecular biomarkers and patient characteristics to individualize therapy for patients with B-cell malignancies

Expiration

May 13, 2023

Discipline(s)

Physician CME

Format

Online

Credits / Hours

0.75

Accreditation

ACCME, ANCC, ACPE

Presenters / Authors / Faculty

Faculty
John P. Leonard, MD

Peer Reviewer
Victor B. Hatcher, PhD

Sponsors / Supporters / Grant Providers

Janssen Biotech, Inc

Keywords / Search Terms

Relias LLC Relias, Free CME, B-cell malignancies Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map